Specifically, we successfully established a model based on 7 IRGs (ULBP2, CCL24, TSLP, FLT3, NPR3, TNFRSF8, and ANO6), which possessed robust performance for judging BC prognosis. This evidence concerns the gene TSLP and breast cancer.